Stepwise

Company Overview

Snapshot

Founded in March 2013 by Simon Robinson and Ofer Zigman, Stepwise operates with 1–10 employees. The company has secured funding across two rounds from RAD BioMed, focusing on developing an ultra-compact laparoscopic stapler.

Business overview

Stepwise is a Health Tech & Life Sciences company specializing in Medical Devices, particularly within Medical Treatment & Therapeutics. The company develops an ultra-compact laparoscopic stapler designed for better maneuverability and reduced tissue trauma, while maintaining high safety standards for thick tissue procedures. Stepwise serves the global healthcare market, targeting providers within the Healthcare & Life Sciences sector.

Company Intelligence Q&A

What is Stepwise's primary product?

Stepwise is developing an ultra-compact laparoscopic stapler that is compatible with 5mm trocars, aiming to improve maneuverability and reduce trauma during surgical procedures.

Who are the founders of Stepwise?

Stepwise was founded by Simon Robinson and Ofer Zigman.

In which sector does Stepwise primarily operate?

Stepwise operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.

What is the current status of Stepwise?

Stepwise is currently non-active and ceased to operate in February 2018.

What is Stepwise developing?

Stepwise is developing an ultra-compact stapler, compatible with 5mm trocar for better maneuverability and less trauma to the surrounding tissues and organs, retaining the same method of stapling and a high safety standard. The stapler is suitable for thick tissue procedures.